Bli medlem
Bli medlem

Du är här



Toronto, Ontario and Kista, Sweden - August 31, 2016 - Prism Medical
Ltd. ("Prism Medical") (TSXV:PM) and Handicare Group AB today
announced the completion of the previously announced arrangement
between Handicare Holdings Ltd. ("Handicare"), an indirect
wholly-owned subsidiary of Handicare Group AB, and Prism Medical
pursuant to which Handicare has acquired all of the outstanding
common shares of Prism Medical for $14.00 per share by way of a court
approved plan of arrangement under the Business Corporations Act

It is expected that the Prism Medical common shares will be delisted
from the TSX Venture Exchange shortly hereafter. Prism also intends
to apply to cease to be a reporting issuer in the applicable
provinces of Canada.


Prism Medical is a vertically integrated manufacturer and leading
provider of equipment and services used to move and handle mobility
challenged individuals in a safe and dignified manner. Prism
Medical's products are marketed under the brand names of Prism
Medical, ErgoSafe, Waverley Glen and Nightingale in the homecare,
acute care and long-term care markets throughout North America. Prism
Medical offers solutions that encourage improved care, quality of
life and mobility, while seeking to lower the overall cost of the
caregiving function in a number of ways, including reducing the
incidence of handling-related injuries among caregivers. Through its
network of dealers, Prism Medical provides an integrated suite of
products and services that make homecare a viable option for many
people. For further information visit Prism Medical's website at or

About Handicare group ab

Handicare was founded in 1986 and supplies technical aids for the
elderly and physically disabled. Its products include stairlifts,
transfer and lifting products, automobile adaptation solutions and
homecare products. Handicare's brand products are distributed through
a comprehensive network of professional dealers and distributors in
30 countries around the world. Through its subsidiary Puls, the group
is also a market leader in the sale of capital goods and consumables
to hospitals and institutions in Norway. Handicare has 950 employees
and its headquarters in Kista, Sweden, and has subsidiaries in
Norway, Denmark, Germany, the Netherlands, England, Belgium, France,
and the US. For more information, please see


This press release contains forward-looking information within the
meaning of applicable securities laws that reflects the current
expectations of management of Prism Medical regarding the Arrangement
and its consummation, including whether conditions to the
consummation of the Arrangement will be satisfied, and the timing for
completing the Arrangement. The words "may", "would", "could",
"should", "will", "anticipate", "believe", "plan", "expect",
"intend", "estimate", "aim", "endeavour", "project", "continue",
"predict", "potential", or the negative of these terms or other
similar expressions have been used to identify these forward-looking

Forward-looking statements are based upon a number of assumptions and
are subject to a number of known and unknown risks and uncertainties,
many of which are beyond management's control, and that could cause
actual results to differ materially from those that are disclosed in
or implied by such forward-looking statements. There can be no
assurance that forward-looking information will prove to be accurate,
as actual results and future events could differ materially from
those expected or estimated in such statements. Accordingly, readers
should not place undue reliance on forward-looking information.

This forward-looking information represents management's views as of
the date of this press release. While subsequent events and
developments may cause such views to change, Prism Medical does not
intend to update this forward-looking information, except as required
by applicable securities laws.

For further information, please contact:

Ross Scavuzzo
Chief Executive Officer
+1 416-260-2145


Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.